Concepedia

Raphäelle Quillet

RQ

Statistics

Publications

5

Citations

184

H-Index

5

Active since

2017

Affiliations

Biotechnologie et Signalisation Cellulaire(Current)

Centre National de la Recherche Scientifique

Université de Strasbourg

Laboratoire d'Innovation Thérapeutique

Université de Bordeaux

Raphäelle Quillet is an author at Biotechnologie et Signalisation Cellulaire specializing in opioid analgesics, pain medicine, and pharmacology.

Publications per year

2017–2021

5

Publications

5

Neuropeptide FF increases M2 activation and self-renewal of adipose tissue macrophages

Syed F. Hassnain Waqas, Anh Cuong Hoang, Ya‐Tin Lin et al. · Journal of Clinical Investigation · 2017 · 85 citations · Full text

, , +17

A bifunctional-biased mu-opioid agonist–neuropeptide FF receptor antagonist as analgesic with improved acute and chronic side effects

Armand Drieu la Rochelle, Karel Guillemyn, Maria Dumitrascuta et al. · Pain · 2018 · 42 citations

, , +17

RF313, an orally bioavailable neuropeptide FF receptor antagonist, opposes effects of RF-amide-related peptide-3 and opioid-induced hyperalgesia in rodents

Khadija Elhabazi, Jean‐Paul Humbert, Isabelle Bertin et al. · Neuropharmacology · 2017 · 24 citations

, , +14

Aminoguanidine Hydrazone Derivatives as Nonpeptide NPFF1 Receptor Antagonists Reverse Opioid Induced Hyperalgesia

Hassan Hammoud, Khadija Elhabazi, Raphäelle Quillet et al. · ACS Chemical Neuroscience · 2018 · 22 citations

, , +17

Identification of an <i>N</i>-acylated-<sup>D</sup>Arg-Leu-NH<sub>2</sub> Dipeptide as a Highly Selective Neuropeptide FF1 Receptor Antagonist That Potently Prevents Opioid-Induced Hyperalgesia

Raphäelle Quillet, Séverine Schneider, Valérie Utard et al. · Journal of Medicinal Chemistry · 2021 · 11 citations · Full text

, , +17

1–5 of 5